Press Releases

Pharming to Directly Commercialise Ruconest in Austria Germany and NetherlandsBiotech company Pharming Group NV ("Pharming" or "the Company") (EURONEXT: PHARM) and Swedish Orphan Biovitrum AB (publ) or "Sobi" (SS: SOBI) today announced the amendment and extension of the Ruconest®...

Therapure Biopharma is appearing at the upcoming BioProcess International Conference & Exhibition. The company can be found at booth number 818. The event takes place from Monday 20 October to Thursday 23 October at Hynes Convention...

Boehringer Ingelheim Pharmaceuticals has introduced Striverdi Respimat (olodaterol) inhalation spray 5µg in the US market. Striverdi Respimat is indicated to treat airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic ...

Eyeforpharma, London, September 2014: Mary Baker, immediate past President of the European Brain Council, believes that pharma companies are focusing too much on patient centricity and instead, should widen their focus to include the whole...

France-based D&A Pharma has entered into an exclusive supply, licensing and distribution agreement with Grupo Juste for Alcover, sodium oxybate, a treatment for alcohol dependence. As part of the deal, Grupo Juste will...

Pfanstiehl has announced the launch of cGMP-produced, high purity Mannose (USP/NF, EP), manufactured in the US under ICH Q7 compliant conditions. "Mannose has long been recognized for playing a key role in protein...

nLife Therapeutics, an early-stage biopharmaceutical company leading developments in nOligos (neuronal specific oligonucleotides) as therapeutic agents for CNS disorders, today announces that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded the company a grant of USD...